<DOC>
	<DOCNO>NCT00985829</DOCNO>
	<brief_summary>The purpose study evaluate efficacy pdt treatment bcc factor affect response rate .</brief_summary>
	<brief_title>Evaluation Efficacy Photodynamic Therapy Basal Cell Carcinoma</brief_title>
	<detailed_description>Background Aim : Basal cell carcinoma ( BCC ) common skin cancer .Photodynamic therapy _as novel , non-invasive therapeutic approach _may consider valuable strategy . This study design aim evaluation efficacy PDT treatment BCC factor may affect response rate . Materials Methods : This clinical trial do 28 BCCs . Patients treat ALA-PDT monthly 1-6 session evaluate clinical response , cosmetic result probable side effect .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<criteria>Histologically proven BCCs rodent ulcer morphea type ANA + history photosensitivity photodermatosis ingestion phototoxic drug last month pregnancy breast feeding age &lt; 18 history another therapeutic intervention bcc last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>basal cell carcinoma</keyword>
	<keyword>photodynamic therapy</keyword>
	<keyword>photo chemotherapy</keyword>
	<keyword>basal cell epithelioma</keyword>
</DOC>